Ken Walsh

Ken is a director in the Life Science practice at Navigant, with more than 15 years of experience across the pharmaceutical industry and consulting.

Ken’s industry roles were as head of pricing in GSK’s emerging markets division based in Brentford and as global head of pricing and market access for Sandoz Biosimilars and Oncology injectables business unit based in Munich.

Prior to moving into industry Ken worked for 10 years in consulting specializing in market access and pricing while based in the USA and Singapore.

Ken has managed/worked on engagements spanning development to commercial strategy in EU, US, and emerging markets:

• Clinical trial design strategy
• BD&L assessments and product/market landscape analysis
• Market access strategy
• Pricing strategy
• Mock Negotiation Workshops
• Launch planning and execution
• Life cycle management

Ken has deep experience across a range of issues and brands within CNS, oncology, and immunology. Additionally, he actively gives presentations at international conferences across a range of market access and public policy issues.